CoChat

Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism

Open access

The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.

Abstract

Oxygen deprivation or hypoxia characterizes a number of serious pathological conditions and elicits a number of adaptive changes that are mainly mediated at the transcriptional level by the family of hypoxia-inducible factors (HIFs). The HIF target gene repertoire includes genes responsible for the regulation of metabolism, oxygen delivery and cell survival. Although the involvement of HIFs in the regulation of carbohydrate metabolism and the switch to anaerobic glycolysis under hypoxia is well established, their role in the control of lipid anabolism and catabolism remains still relatively obscure. Recent evidence indicates that many aspects of lipid metabolism are modified during hypoxia or in tumor cells in a HIF-dependent manner, contributing significantly to the pathogenesis and/or progression of cancer and metabolic disorders. However, direct transcriptional regulation by HIFs has been only demonstrated in relatively few cases, leaving open the exact and isoform-specific mechanisms that underlie HIF-dependency. This review summarizes the evidence for both direct and indirect roles of HIFs in the regulation of genes involved in lipid metabolism as well as the involvement of HIFs in various diseases as demonstrated by studies with transgenic animal models.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells8030214

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Regulation of hypoxia-inducible factor (HIF) by oxygen. (A) Under physiological oxygen concentration (Normoxia), HIF-α isoforms are modified by oxygen-dependent prolyl-hydroxylases (PHDs), recognized by the von Hippel–Lindau (VHL) tumor suppressor protein, ubiquitinated and targeted to the proteasome for degradation. In addition, HIF-α modification by FIH (factor-inhibiting HIF), an oxygen-sensitive asparaginyl hydroxylase, disrupts interaction with the transcriptional co-activators p300/CBP and impairs residual HIF transcriptional activity. (B) When oxygen becomes limited (Hypoxia), PHDs and FIH are inactive. The non-hydroxylated HIF-α is stable and dimerizes with HIF-1β. The HIF heterodimer interacts with p300/CBP and activates the transcription of HIF target genes.
Figure 1 Regulation of hypoxia-inducible factor (HIF) by oxygen. (A) Under physiological oxygen concentration (Normoxia), HIF-α isoforms are modified by oxygen-dependent prolyl-hydroxylases (PHDs), recognized by the von Hippel–Lindau (VHL) tumor suppressor protein, ubiquitinated and targeted to the proteasome for degradation. In addition, HIF-α modification by FIH (factor-inhibiting HIF), an oxygen-sensitive asparaginyl hydroxylase, disrupts interaction with the transcriptional co-activators p300/CBP and impairs residual HIF transcriptional activity. (B) When oxygen becomes limited (Hypoxia), PHDs and FIH are inactive. The non-hydroxylated HIF-α is stable and dimerizes with HIF-1β. The HIF heterodimer interacts with p300/CBP and activates the transcription of HIF target genes.CC BY · PubMed Central
Figure 2 Positive and negative regulation of HIF-1α by phosphorylation. Direct phosphorylation by several kinases is important for HIF-1α regulation. Positive regulation: ERK1/2-dependent phosphorylation inhibits binding of the exportin CRM1 and promotes nuclear accumulation of HIF-1α, while phosphorylation by ATM, CDK1 or PKA inhibits HIF-1α degradation. Negative regulation: phosphorylation by casein CK1δ impairs HIF-1α association with ARNT and thus, decreases HIF-1 transcriptional activity, while phosphorylation by GSK3 or Plk3 results in VHL-independent degradation of HIF-1α. See text for details and references.
Figure 2 Positive and negative regulation of HIF-1α by phosphorylation. Direct phosphorylation by several kinases is important for HIF-1α regulation. Positive regulation: ERK1/2-dependent phosphorylation inhibits binding of the exportin CRM1 and promotes nuclear accumulation of HIF-1α, while phosphorylation by ATM, CDK1 or PKA inhibits HIF-1α degradation. Negative regulation: phosphorylation by casein CK1δ impairs HIF-1α association with ARNT and thus, decreases HIF-1 transcriptional activity, while phosphorylation by GSK3 or Plk3 results in VHL-independent degradation of HIF-1α. See text for details and references.CC BY · PubMed Central
Figure 3 Reprogramming of lipid metabolism under hypoxia. Hypoxia enhances lipogenesis by HIF-dependent modulation of proteins involved in fatty acid (FA) uptake, synthesis, storage and usage. Uptake of extracellular FA is promoted under hypoxia by activation of the transcription factor PPARγ and the increased expression of FABPs 3, 4 and 7. Endocytosis of lipoproteins is enhanced by the upregulation of LRP1 and VLDLR, while ceramide levels are increased by upregulation of NEU3. To maintain de novo FA synthesis under hypoxia, preservation of citrate levels and synthesis of acetyl-CoA is achieved by stimulation of reductive glutamine metabolism, mediated, at least in part, by induction of GLS1 and proteolysis of the OGDH2 subunit of the α-ketoglutarate dehydrogenase complex (αKGDH) by SIAH2. Adequate FA supply is further supported by activation of SREBP-1, which in turn upregulates the expression of FASN. To avoid lipotoxicity and/or replete lipid stores, FAs are converted to neutral triacylglycerols (TAGs), which are stored in lipid droplets (LDs). Formation of LDs under hypoxia is favored by the upregulation of the TAG biosynthesis pathway enzymes AGPAT2 and lipin-1, and the LD membrane proteins PLIN2 and HIG2. Finally, lipid accumulation under hypoxia is additionally supported by the inhibition of β-oxidation through downregulation of PGC-1α, CPT1A, PGC-1β, MCAD and LCAD. The proteins upregulated or activated under hypoxia are shown in red and the proteins downregulated or inhibited under hypoxia are shown in green. See text for details and references.
Figure 3 Reprogramming of lipid metabolism under hypoxia. Hypoxia enhances lipogenesis by HIF-dependent modulation of proteins involved in fatty acid (FA) uptake, synthesis, storage and usage. Uptake of extracellular FA is promoted under hypoxia by activation of the transcription factor PPARγ and the increased expression of FABPs 3, 4 and 7. Endocytosis of lipoproteins is enhanced by the upregulation of LRP1 and VLDLR, while ceramide levels are increased by upregulation of NEU3. To maintain de novo FA synthesis under hypoxia, preservation of citrate levels and synthesis of acetyl-CoA is achieved by stimulation of reductive glutamine metabolism, mediated, at least in part, by induction of GLS1 and proteolysis of the OGDH2 subunit of the α-ketoglutarate dehydrogenase complex (αKGDH) by SIAH2. Adequate FA supply is further supported by activation of SREBP-1, which in turn upregulates the expression of FASN. To avoid lipotoxicity and/or replete lipid stores, FAs are converted to neutral triacylglycerols (TAGs), which are stored in lipid droplets (LDs). Formation of LDs under hypoxia is favored by the upregulation of the TAG biosynthesis pathway enzymes AGPAT2 and lipin-1, and the LD membrane proteins PLIN2 and HIG2. Finally, lipid accumulation under hypoxia is additionally supported by the inhibition of β-oxidation through downregulation of PGC-1α, CPT1A, PGC-1β, MCAD and LCAD. The proteins upregulated or activated under hypoxia are shown in red and the proteins downregulated or inhibited under hypoxia are shown in green. See text for details and references.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 335

Metadata

Authors
Mylonis, I., Simos, G., & Paraskeva, E.
Affiliations
University of Thessaly (GR)
Corresponding author
  • Simos, George
  • Paraskeva, Efrosyni
Venue
Cells
Publisher
MDPI AG
Published
2019-03-03
Volume
8
Issue
3
Pages
214
ISSN
2073-4409 (ISSN-L)
OpenAlex
W2919736532
Cited by
316
References
118
Citations by year
2026: 41 · 2025: 52 · 2024: 42 · 2023: 46 · 2022: 48 · 2021: 57 · 2020: 25 · 2019: 5
FWCI
3.26
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
Funders
Research Committee, University of Thessaly (5309.17.03)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
hypoxia-inducible factor, lipid metabolism, hypoxia, transcriptional regulation, lipid degradation, cancer cells, tumor progression, metabolic disorders, transgenic animal models
MeSH terms
Animals, Hypoxia, Cardiovascular Diseases, Humans, Neoplasms, Oxygen, Lipid Metabolism, Hypoxia-Inducible Factor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.